Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Tables)

v3.21.2
Accrued Expenses (Tables)
6 Months Ended
Jun. 30, 2021
Payables And Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consisted of the following as of June 30, 2021 and December 31, 2020 (in thousands):

 

 

 

June 30, 2021

 

 

December 31, 2020

 

External research and preclinical development

 

$

6,252

 

 

$

4,702

 

Employee compensation and benefits

 

 

2,992

 

 

 

5,715

 

Professional fees

 

 

682

 

 

 

602

 

Facilities and other

 

 

37

 

 

 

65

 

 

 

$

9,963

 

 

$

11,084